Baicalin and ginsenoside Rb1 suppress the activation of cardiac fibroblasts via regulating the GRK2/AT1R/MasR network
Authors:
- 4 October 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 148, 157371
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82174009)
This publication has 38 references indexed in Scilit:
- Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approachEuropean Journal of Pharmacology, 2024
- A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiationBiomedicine & Pharmacotherapy, 2022
- Angiotensin II receptor type 1 – An update on structure, expression and pathologyBiochemical Pharmacology, 2021
- Biomarkers for the diagnosis and management of heart failureHeart Failure Reviews, 2021
- Biomarkers in heart failure: the past, current and futureHeart Failure Reviews, 2019
- Adipose tissue derived-factors impaired pancreatic β-cell function in diabetesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talkBest Practice & Research Clinical Endocrinology & Metabolism, 2018
- Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathwayArchives of Biochemistry and Biophysics, 2018
- Adipose tissue conditioned media support macrophage lipid-droplet biogenesis by interfering with autophagic fluxBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure ProgressionJACC, 2017